At a glance
ClinicalIndex Comparison RecordN/ACompleted· 16 enrolled
Drug / intervention
Oral Irondrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Effect of Oral Iron Therapy on Erythrocyte Protoporphyrin Levels in the Erythropoietic Protoporphyrias
In Brief
A clinical study evaluating Oral Iron for Erythropoietic Protoporphyria and 3 related conditions. Completed, enrolled 16 participants across 6 sites.
Detailed Summary
In the medical literature there are conflicting reports on whether iron improves symptoms in patients with EPP and XLP. Giving iron to people who are iron deficient is thought to improve EPP symptoms. However, this has never been systematically tested. Therefore, the purpose of this study is to determine the effect of oral iron for EPP and XLP patients.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsErythropoietic Protoporphyria, EPP, X-linked Protoporphyria, XLP
CountriesUnited States
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedDec 2016
Enrollment StartDec 2016
Primary CompletionJul 2019
TodayJul 2026
First PostedDec 1, 2016
Enrollment StartDec 1, 2016
Primary CompletionJul 19, 2019
TodayJul 2, 2026
Enrollment to primary: 2.6 yearsPosted 9.6 years ago
Interventions
Oral Irondrug
for one year